3M Expands Facility In Valley, Nebraska; $67M Investment To Create 40 Jobs
The $67 million investment includes new production lines, equipment and a warehouse, and will help 3M more quickly meet customer demand for the company's personal safety products. The expansion of the
3M Is Maintained at Neutral by UBS
3M Is Maintained at Neutral by UBS
UBS Maintains Neutral on 3M, Raises Price Target to $100
UBS analyst Damian Karas maintains 3M with a Neutral and raises the price target from $98 to $100.
3M Price Target Raised to $111.00/Share From $110.00 by JP Morgan
3M Price Target Raised to $111.00/Share From $110.00 by JP Morgan
3M Raised to Overweight From Neutral by JP Morgan
3M Raised to Overweight From Neutral by JP Morgan
Komo: The 3M (MMM.US) rating was raised from neutral to an increase in holdings rating, and the target price was adjusted from $110.00 to $111.00.
Komo: The 3M (MMM.US) rating was raised from neutral to an increase in holdings rating, and the target price was adjusted from $110.00 to $111.00.
3M Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 11.9% JP Morgan $110 → $111 Upgrades Neutral → Overweight 04/17/2024 10.89% JP Morgan $118 → $1
RBC Capital Adjusts Price Target on 3M Company to $87 From $78
08:18 AM EDT, 05/01/2024 (MT Newswires) -- RBC Capital Adjusts Price Target on 3M Company to $87 From $78 Price: 97.62, Change: +1.11, Percent Change: +1.15
3M Upgraded at J.P. Morgan on Key Catalysts, Healthcare Spinoff
JPMorgan Upgrades 3M to Overweight From Neutral, Adjusts Price Target to $111 From $110
3M (MMM) has an average rating of hold and price targets ranging from $87 to $112, according to analysts polled by Capital IQ. Price: 97.70, Change: +1.19, Percent Change: +1.23
Express News | “Dividend Aristocrat” 3M plans to drastically cut dividends for the first time in more than 60 years
Equity Markets Down Ahead of Amazon Earnings
US benchmark equity indexes were lower ahead of Tuesday's close, as investors assessed the latest corporate earnings and awaited Amazon.com's (AMZN) results. The Dow Jones Industrial Average and the N
Live On CNBC, Stephanie Link Announces Bought More 3M
Live On CNBC, Stephanie Link Announces Bought More 3M
3M Says In Q1 2024 Co Approved & Committed To Undertake Additional Actions Impacting About 500 Positions Resulting In A Pre-Tax Charge Of $104M
3M Says In Q1 2024 Co Approved & Committed To Undertake Additional Actions Impacting About 500 Positions Resulting In A Pre-Tax Charge Of $104M
3M on Track for Highest Close Since February 2023 -- Data Talk
3M Company (MMM) is currently at $96.46, up $4.31 or 4.67% --Would be highest close since Feb. 7, 2023, when it closed at $97.74 --On pace for largest percent increase since April 1, 2024, when it r
Melius Research Adjusts 3M's Price Target to $92 From $122
3M (MMM) has an average rating of hold and price targets ranging from $78 to $111.57, according to analysts polled by Capital IQ. Price: 97.02, Change: +4.86, Percent Change: +5.27
Changes in US stocks 丨 3M rose more than 4% Q1 net sales and adjusted earnings per share exceeded expectations
On April 30, Gelonghui | 3M (MMM.US) rose more than 4% to $95.87. 3M's net sales for the first quarter were US$8 billion, with market expectations of US$7.63 billion; adjusted earnings per share were US$2.39, and market expectations were US$2.1. 3M expects a dividend payout ratio of approximately 40% of total free cash flow.
3M Is 'Resetting' Its Dividend. Why Its Stock Is Soaring. -- Barrons.com
3M's quarterly earnings topped Wall Street estimates -- a positive -- but what the company said about its dividend should get most of the attention.
Market-Moving News for April 30th
MMM: 8.3% | 3M shares are trading higher following a Q1 earnings beat, reversing after initially falling.CYCC: 103% | Cyclacel Pharmaceuticals shares are trading higher after the company announced tha
Research Alert: CFRA Keeps Hold Opinion On Shares Of 3m Company
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: In line with CFRA's expectations, MMM an
No Data